Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: Results from the WHO MONICA project

International Journal of Epidemiology

Volumn 34, Issue 1, 2005, Pages 181-192

  Tolonen, Hanna ^a   Keil, Ulrich ^b   Ferrario, Marco ^c   Evans, Alun ^d   Hobbs, M S T ^a,e   Jamrozik, K ^e   Thompson, P L ^e   Armstrong, B K ^e   Dobson, A ^a,f   Leeder, S ^b,f   Alexander, H ^f   Heller, R ^f   De Backer, G ^a,g   De Henauw, S ^g   De Bacquer, D ^g   De Craene, I ^g   Van Der Haegen, M R ^g   De Maeyer, M ^g   Bellemans, M ^g   Kornitzer, M ^a,h   Berghmans, L ^h   Darquennes, H ^h   Kittel, F ^h   Lagasse, R ^h   Gregor, R D ⁱ   Bata, I R ⁱ   Wolf, H K ⁱ   Brownell, B ⁱ   Webber, K ⁱ   Zhaosu, Wu ^a,j   Yingkai, Wu ^b,j   Chonghua, Yao ^j   Ruisong, Zhang ^j   Skodova Z ^a,k   Pisa Z ^k   Hejl, Z ^k   Vojtisek P ^k   Emrova R ^k   Cicha Z ^k   Berka, L ^k   Hoke, M ^k   Pikhartova J ^k   Hrdlickova K ^k   Wiesner, E ^k   Poledne, R ^k   Grafnetter, D ^k   Schroll, M ^a,l   Kirchhoff, M ^l   Sjol, A ^l   Quitsau Lund, S ^l   Ducimetiere, P ^c,m   Richard, D J ^d,m   Bingham, A ^m   Ferrieres, J ^a,m   Cambou, J P ^b,m   Ruidavets, J B ^m   Branchu, M P ^m   Delmas, V ^m   Rodier, P ^m   Arveiler, D ^a,n   Schaffer, P ^a,n   Escudero, I ⁿ   Baas, V ⁿ   Pierau, F ⁿ   Amouyel, P ^a,o   Montaye Faivre, M ^a,o   Salomez, J L ^b,o   Nuttens, M C ^b,o   Graux, C ^o   Marecaux, N ^o   Greiser, E ^a,p   Herman, B ^e,p   Barth, W ^a,q   Heinemann, L ^a,q   Assmann, A ^q   Bothig S ^q   Voigt, G ^q   Brasche, S ^q   Quietzsch, D ^q   Classen, E ^q   Sigfusson, N ^a,r   Gudmundsdottir, I I ^r   Stefansdottir, I ^r   Thorsteinsson, Th ^r   Sigvaldason, H ^r   Giampaoli, S ^s   Vanuzzo, D ^a,t   Feruglio, G A ^b,t   Palmieri, M ^t   Spanghero, M ^t   Scarpa, M ^t   Pilotto, L ^t   Cignacco, G B ^t   Marini, R ^t   Zilio, G ^t   Cesana, G C ^a,u   Ferrario, M ^a,u   Sega, R ^u   Mocarelli, P ^u   more..

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g GHENT UNIVERSITY   (Belgium)

^h FREE UNIVERSITY OF BRUSSELS   (Belgium)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j Beijing Heart and Lung Blood Vessel Disease Institute   (China)

^k INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m INSERM   (France)

ⁿ UNIVERSITÉ DE STRASBOURG   (France)

^o INSTITUT PASTEUR DE LILLE   (France)

^p LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^q Berlin Center for Epidemiology and Health Research   (Germany)

^r Heart Preventive Clinic Reykjavik   (Iceland)

^s ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^t Regional Hospital   (Italy)

^u UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Awareness; Cholesterol; Population study; Prevalence; Standardization; Treatment

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL;

DISEASE CONTROL; DISEASE PREVALENCE; HYPERTENSION; STANDARD (REFERENCE); WORLD HEALTH ORGANIZATION;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; AWARENESS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GEOGRAPHY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT CARE; PATIENT MONITORING; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; SEX DIFFERENCE; STANDARDIZATION; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

ADULT; ANTILIPEMIC AGENTS; CHOLESTEROL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; WORLD HEALTH ORGANIZATION;

EID: 20044366891     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyi056     Document Type: Article

References (42)

1. al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. Int J Cardiol 1996;54:41-49.
2. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 2001;79:908-15.
3. Gnasso A, Calindro MC, Carallo C et al. Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy. Eur J Epidemiol 1997;13:421-28.
4. Hughes K, Aw TC, Choo MH. Hypercholesterolaemia and its treatment in Singapore with implications for screening. Ann Acad Med Singapore 1997;26:449-52.
5. Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. Circulation 1998;97:1087-94.
6. Nieto FJ, Alonso J, Chambless LE et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med 1995; 155:677-84.
7. Simon A, Dimberg L, Levenson J et al. Comparison of cardiovascular risk profile between male employees of two automotives companies in France and Sweden. The Coeur Project Group. Eur J Epidemiol 1997;13:885-91.
8. Ulmer H, Diem G, Bischof HP, Ruttmann E, Concin H. Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area. Wien Klin Wochenschr 2001;113:573-79.
9. Wu DM, Pai L, Chu NF et al. Prevalence and clustering of cardiovascular risk factors among healthy adults in a Chinese population: the MJ Health Screening Center Study in Taiwan. Int J Obes Relat Metab Disord 2001;25:1189-95.
10. Cirera L, Tormo MJ, Chirlaque MD, Navarro C. Cardiovascular risk factors and educational attainment in Southern Spain: a study of a random sample of 3091 adults. Eur J Epidemiol 1998; 14:755-63.
11. Polednak AP. Awareness and use of blood cholesterol tests in 40-74-year-olds by educational level. Public Health Rep 1992; 107:345-51.
12. Salomaa V, Korhonen HJ, Tuomilehto J et al. Serum cholesterol distribution, measurement frequency and cholesterol awareness in three geographical areas of Finland. Eur Heart J 1990; 11: 94-301.
13. From the Centers for Disease Control. Factors related to cholesterol screening, cholesterol level awareness-United States, 1989. JAMA 1990;264:2985-86.
14. State-specific cholesterol screening trends-United States, 1991-1999. MMWR Morb Mortal Wkly Rep 2000;49:750-55.
15. Brown DW, Giles WH, Greenlund KJ, Croft JB. Disparities in cholesterol screening: falling short of a national health objective. Prev Med 2001;33:517-22.
16. Ovhed I, Odeberg H, Troein M, Rastam L. Awareness and treatment of cardiovascular disease risk factors among middle-aged Swedish men and women. Scand J Prim Health Care 1998;16: 65-70.
17. Marques-Vidal P, Arveiler D, Evans A, Amouyel P, Ferrieres J, Luc G, Ducimetiere P. Awareness, treatment and control of hyperlipidaemia in middle-aged men in France and northern ireland in 1991-1993: the PRIME study. Prospective epidemiological study of myocardial infarction. Acta Cardiol 2002;57:117-23.
18. Burke GL, Sprafka JM, Folsom AR, Hahn LP, Luepker RV, Blackburn H. Trends in serum cholesterol levels from 1980 to 1987. The Minnesota Heart Survey. N Engl J Med 1991;324:941-46.
19. Tunstall-Pedoe H, for the WHO MONICA Project, editors. MONICA Monograph and Multimedia Sourcebook. Geneva: World Health Organization; 2003.
20. Tunstall-Pedoe H, for the WHO MONICA Project. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988;41: 05-14.
21. WHO MONICA Project. MONICA Manual, Part III: Population Survey, Section 1: Population Survey Data Component. (1997). Available from: URL: http://www.ktI.fi/publications/monica/manual/part3/iii-1.htm, URN:NBN:fi-fe19981151
22. WHO MONICA Project. MONICA Manual, Part III: Population Survey, Section 2: Standardization of lipid measurements. (1998). Available from: URL:http://www.ktl.fi/publications/monica/manual/part3/iii-2.htm, URN:NBN:fi-fe19981152
23. Ferrario M, Kuulasmaa K, Grafnetter D, Moltchanov V, for the WHO MONICA Project. Quality Assessment of Total Cholesterol Measurements in the WHO MONICA Project. (1999). Available from: URL:http://www.ktl.fi/publications/monica/tchol/tcholqa.htm, URN:NBN: fi-fe19991083
24. Tolonen H, Ferrario M, Minoja M, for the WHO MONICA Project. Quality Assessment of Data on Awareness and Treatment of High Cholesterol in the WHO MONICA Project. (1999). Available from: URL:http://www.ktl.fi/publications/monica/hich/hchdrug.htm, URN:NBN: fi-fe19991130
25. Waterhouse J, Muir CS, Correa P, Powell J (eds). Cancer Incidence in Five Continents. Lyon: IARC; 1976.
26. Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey. J Clin Epidemiol 1993;46:561-71.
27. Johansson J, Hellenius ML, Elofsson S, Krakau I. Self-report as a selection instrument in screening for cardiovascular disease risk. Am J Prev Med 1999;16:322-24.
28. Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 1997;35:932-47.
29. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002;11:379-84.
30. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997;50:619-25.
31. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000;53:273-77.
32. Sans S, Paluzie G, Puig T, Balana L, Balaguer-Vintro II. [Prevalence of drug utilization in the adult population of Catalonia, Spain]. Gac Sanit 2002;16:121-30.
33. Biemer PP, Groves RM, Lyberg LE, Mathiowetz NA, Sudman S (eds). Measurement Errors in Surveys. New York: John Wiley & Sons, Inc.; 1991.
34. Neutel CI, Walop W. Comparing two different approaches to measuring drug use within the same survey. Chronic Dis Can 2000; 21:150-56.
35. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). J Cardiovasc Risk 2003;10:S1-S10.
36. Korkeila K, Suominen S, Ahvenainen J et al. Non-response and related factors in a nation-wide health survey. Eur J Epidemiol 2001;17:991-99.
37. Strandberg TE, Salomaa VV, Vanhanen HT, Naukkarinen VA, Sarna SJ, Miettinen TA. Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study. Br Heart J 1995; 74:449-54.
38. Cottler LB, Zipp JF, Robins LN, Spitznagel EL. Difficult-to-recruit respondents and their effect on prevalence estimates in an epidemiologic survey. Am J Epidemiol 1987;125:329-39.
39. Strasser T. Hypertension: the East European experience. Am J Hypertens 1998;11(6 Pt 1):756-8.
40. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-31.
41. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 434-503.
42. Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H, the European Health Risk Monitoring Project. Recommendation for Indicators, International Collaboration, Protocol and Manual of Oprations for Chronic Disease Risk Factor Surveys. (2002). Available from: URL:http://www.ktl.fi/publications/ehrm/product2/title.htm, URN:NBN:fi-fe20021443